Transaction provides $247 million in gross proceeds to support newcleo’s U.S. and European growth, advance its lead-cooled fast reactor and MOX nuclear fuel production towards commercialization
LI BANG INTERNATIONAL CORPORATION INC. Announces Adjournment of Extraordinary General Meeting
JIANGYIN, China, Sept. 21, 2026 (GLOBE NEWSWIRE) — Li Bang International Corporation Inc. (“Li Bang International”) and its subsidiaries (collectively, the “Company,” “we,” “us,” “our company,” or “Li Bang”) (Nasdaq: LBGJ), a company engaged in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China, today announced that its Extraordinary General Meeting of Shareholders (the “Meeting”) has been adjourned to September 22, 2026 at 9:30 a.m., Eastern Time, at the Company’s principal office, due to the absence of a quorum.
VisitMercerCountyPA Highlights Homecoming Shopping Across Mercer County, Pennsylvania
Students and families can shop for dresses, shoes, handbags, jewelry, and accessories in Sharon, Hermitage, and Grove City.
LI BANG INTERNATIONAL CORPORATION INC. Announces Adjournment of Extraordinary General Meeting
JIANGYIN, China, Sept. 21, 2026 (GLOBE NEWSWIRE) — Li Bang International Corporation Inc. (“Li Bang International”) and its subsidiaries (collectively, the “Company,” “we,” “us,” “our company,” or “Li Bang”) (Nasdaq: LBGJ), a company engaged in designing, developing, producing, and selling stainless steel commercial kitchen equipment in China, today announced that its Extraordinary General Meeting of Shareholders (the “Meeting”) has been adjourned to September 22, 2026 at 9:30 a.m., Eastern Time, at the Company’s principal office, due to the absence of a quorum.
VisitMercerCountyPA Highlights Homecoming Shopping Across Mercer County, Pennsylvania
Students and families can shop for dresses, shoes, handbags, jewelry, and accessories in Sharon, Hermitage, and Grove City.
H2O America Receives Regulatory Approval for Texas Subsidiary’s Cibolo Valley Acquisition
Vireo Growth Inc. Completes Acquisition of M3 Wellness, a Nevada Dispensary
Forward Industries’ SOL Holdings Rise to Approximately 8.16 Million SOL
AUSTIN, TX, Sept. 21, 2026 (GLOBE NEWSWIRE) — Forward Industries, Inc. (NASDAQ: FWDI) (the “Company” or “Forward”), the leading Solana treasury company, today provided an update on its SOL treasury holdings.
Thomas P. Clement Professorship Established at Howard Community College, Anchoring a Growing Engineering Innovation Ecosystem
Howard Community College Professor and Department Head of Engineering Dr. Ghazanfer Bozai will serve as the inaugural holder for a five-year term beginning this fall.
Record Settlement Volume Driven by SPAC Litigation, While Settlement Values Fall Sharply – Cornerstone Research
Record Settlement Volume Driven by SPAC Litigation, While Settlement Values Fall Sharply Cornerstone Research
Sutter Health Names Christina Oh Executive Vice President and Chief Operating Officer
SAN FRANCISCO, Sept. 21, 2026 (GLOBE NEWSWIRE) — Sutter Health today announced that Christina Oh has been named executive vice president and chief operating officer. She will expand her operational leadership role at the not-for-profit, integrated health system as it continues to enhance access, strengthen performance and advance more coordinated and advanced clinical care close to home for patients and communities.
Data Catalog Market Accelerates as AI-Powered Discovery Strengthens Enterprise Data Governance and AI Readiness
U.S. Mint and America’s VetDogs Unveil Final Designs for 2027 Working Dog Commemorative Coins
Gold, Silver, and Clad Coins Honor Therapy Dogs, Guide and Service Dogs, and Military and Law Enforcement K9s; Surcharges Will Support America’s VetDogs
Psoriatic Arthritis Market Landscape: 6 Key Late-Stage Drugs Set to Drive Future Growth | DelveInsight
The launch of emerging therapies such as ILUMYA/ILUMETRI (tildrakizumab-asmn; Sun Pharma), Izokibep (Affibody Medical), ICOTYDE (icotrokinra; Johnson & Johnson), Zasocitinib (TAK-279; Takeda), Sonelokimab (MoonLake Immunotherapeutics), Vunakizumab (Suzhou Suncadia), SPY 072 (Spyre Therapeutics), PN-881 (Protagonist Therapeutics), and others is expected to significantly reshape the Psoriatic Arthritis (PsA) market by expanding treatment options and addressing unmet needs among patients with inadequate responses to existing therapies.
Amundi : Programme de rachat d’actions – Déclaration des transactions sur actions propres réalisées du 14 septembre au 18 septembre 2026
Paris, 21 septembre 2026 – (Article 5 du règlement (UE) n° 596/2014 sur les abus de marché et Article 3 (3) du règlement délégué (UE) 2016/1052 complétant le règlement (UE) n° 596/2014 par des normes techniques de réglementation concernant les conditions applicables aux programmes de rachat et aux mesures de stabilisation).
European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)
Basel, 21 September 2026 – Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the European Commission has approved Susvimo® (ranibizumab 100 mg/mL solution for injection) for the treatment of neovascular age-related macular degeneration (nAMD), a leading cause of vision loss in people over the age of 60.5,6
New Bridgespan Research Identifies What Shapes—and What Constrains—Indian American Diaspora Giving
Drawing on 60-plus interviews, the research points to trusted information, stronger networks, and easier cross-border giving as the keys to greater impact.
Northmarq expands investment platform with acquisition of Thirdline Capital Management
FingerMotion Advances 99 MW Alberta Program with Second Campus: Binding Letter of Intent to Acquire Powered Land in Hanna
Second campus under the Company’s 99 MW Alberta program; site offers 3 MW of grid power and a natural gas interconnection for behind-the-meter generation, planned as a 9.9 MW campus for AI and high-performance computing clients